(19)
(11) EP 1 138 329 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.05.2006 Bulletin 2006/20

(45) Mention of the grant of the patent:
02.06.2004 Bulletin 2004/23

(21) Application number: 01107235.2

(22) Date of filing: 15.02.1990
(51) International Patent Classification (IPC): 
A61K 31/44(1985.01)
 A61P 43/00(2000.01)

(54)

Composition containing 5-Methyl-1-phenyl-2-(1 H)-pyridone for reparation and prevention of fibrotic lesions

Zusammensetzung, welche 5-Methyl-1-phenyl-2-(1 H)-pyridone enthält, zur fixierung und Vermeidung von fibrotischen Schädigungen

Composition, qui contient 5-Methyl-1-phenyl-2-(1 H)-pyridone, pour réparer et prévenir des lésions fibrotiques

(84) Designated Contracting States:
BE DE ES FR GB IT

(30) Priority: 15.02.1989 JP 3543689

(43) Date of publication of application:
04.10.2001 Bulletin 2001/40

(62) Application number of the earlier application in accordance with Art. 76 EPC:
90301607.9 / 0383591

(73) Proprietors:
  • Yamauchi, Shitotomo
    Chiyoda, Tokyo 102 (JP)
  • MARGOLIN, Solomon B.
    Dallas, Texas 75225 (US)

(72) Inventor:
  • Margolin, Solomon B.
    Dallas, Texas 75225 (US)

(74) Representative: Bannerman, David Gardner et al
Withers & Rogers LLP Goldings House, 2 Hays Lane
London SE1 2HW
London SE1 2HW (GB)


(56) References cited: : 
US-A- 4 042 699
   
  • MARGOLIN: "removal of interstitial chemotherapy..." FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, vol. 41, no. 5, 1982, XP008000826 new orleans
  • ROBERTS: "pirfenidone" DRUGS OF THE FUTURE, vol. 11, no. 6, - 1977 pages 396-397, XP008000834
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).